WhitestoneREIT (NYSE... Terns Pharmaceuticals, Inc. (NASDAQ. TERN)'s sale to Merck for $53.00 per share in cash. If you are a Terns shareholder, click here to learn more about your rights and options. Rallybio Corporation (NASDAQ ... (NASDAQ ... 21% ... .
MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Terns (NASDAQ. TERN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Merck ... .
MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Terns (NASDAQ. TERN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Merck ... .
Except as indicated in this Solicitation/Recommendation Statement (including the exhibits hereto), Terns is not undertaking or engaging in any negotiations in response to the Offer that relate to (i) ...
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue ...Washington, D.C ... Terns Pharmaceuticals, Inc. [TERN] 5 ... C/O TERNS PHARMACEUTICALS, INC., 1065 E ... C/O TERNS PHARMACEUTICALS, INC ... Terns Pharmaceuticals Inc.